AtaCor Medical

San Clemente, United States Founded: 2014 • Age: 12 yrs
An implantable pacemaker system is developed for cardiac pacing therapy.

About AtaCor Medical

AtaCor Medical is a Healthcare company based in San Clemente (United States) founded in 2014 by Alan Marcovecchio, Rick Sanghera, and Sean McGeehan. An implantable pacemaker system is developed for cardiac pacing therapy. AtaCor Medical has raised $136.8 million across 4 funding rounds from investors including Longview Partners, Broadview Ventures and aMoon. The company has 15 employees. Its chief executive, as recorded, is Rick Sanghera. AtaCor Medical offers products and services including EV Temporary Pacing Lead System and EV-ICD Lead System. Its focus areas include Life Sciences, Cardiac and Vascular Disorders, Medical Devices and Therapeutic Devices. Its legal entity is ATACOR MEDICAL, INC. Its competitors include AtriCure, CardioFocus and Kestra Medical Technologies; 2 of its 3 listed competitors have raised funding.

Company details

Founded in 2014 and based in San Clemente, United States, AtaCor Medical operates in the medical device sector. An implantable pacemaker system is being developed, with the lead positioned in tissue above the heart to deliver pacing therapy. No leads or hardware are required inside or on the heart. Ventricular pacing or AV synchronous nodal therapy is enabled through this approach.

  • Headquarters San Clemente, United States
  • Employees 15
  • Founders Alan Marcovecchio, Rick Sanghera, Sean McGeehan
  • Sectors
    Healthcare
  • Email
    β€’β€’β€’β€’β€’β€’β€’β€’
  • Phone
    β€’β€’β€’β€’ β€’β€’β€’β€’
  • Website atacor.com
  • Social LinkedIn X
  • Legal Name Atacor Medical, Inc.
Key Metrics
  • Total Equity Funding
    $136.8M (USD)

    in 4 rounds

  • Latest Funding Round
    $75M (USD), Series D

    Oct 2025

  • Investors
  • Employee Count
    15

Products & Services of AtaCor Medical

AtaCor Medical offers a comprehensive portfolio of products and services, including EV Temporary Pacing Lead System and EV-ICD Lead System.

EV Temporary Pacing Lead System
Pacing Device

Provides temporary pacing without entering the heart or vascular system.

EV-ICD Lead System
Defibrillation Device

Delivers defibrillation and ATP without transvenous leads for safety.

Funding Insights of AtaCor Medical

AtaCor Medical has successfully raised a total of $136.8M across 4 strategic funding rounds. The most recent funding activity was a Series D round of $75 million completed in October 2025. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding $136.8M
  • Total Rounds 4
  • Last Round Series D β€” $75M
  • First Round $8.8M

    (Sep 2018)

  • Investors Count 7

All 4 funding rounds of AtaCor Medical with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
Oct 2025$75MSeries D––
–
Apr 2024$28MSeries C–Arboretum Ventures
Apr 2020$25MSeries B–Longview Partners, Hatteras Venture Partners
Sep 2018$8.8MSeries A–Broadview Ventures, aMoon
–
Valuation history

7 investors in total: 7 institutional.

Investors in AtaCor Medical

AtaCor Medical has secured backing from 7 investors, including venture fund and institutional investors. Prominent investors backing the company include Longview Partners, Broadview Ventures and aMoon.

All
Venture Fund
Institutional
InvestorDescriptionFounded YearDomainLocation
Seed-stage life sciences investments are made in the US.
broadviewventures.orgBoston, United States
Venture capital investments in healthcare are focused on by aMoon.
amoon.fund
Tech & Life Sciences focused VC firm investing in early stage companies in the US & Europe
hatterasvp.comDurham, United States
chv.vc
Healthcare venture capital investments are made by Arboretum Ventures.
arboretumvc.comAnn Arbor, United States
BayMed Venture Partners is focused on investing in early-stage medical device and digital health companies.
baymedvp.comSan Francisco, United States
Investment management services are provided by Longview Partners in London.
2001longview-partners.comLondon, United Kingdom
Premium access

Investor details for AtaCor Medical

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

People of AtaCor Medical

22 people are tracked at AtaCor Medical (9 in leadership, 8 in board & advisors, 5 in team); the tracked headcount is 15.

NameRoleGroup
Alan Marcovecchio
Co-Founder & PresidentLeadership
Rick Sanghera
Co-Founder & CEOLeadership
Sean McGeehan
Co-Founder & CFOLeadership
Martin Burke
Chief Medical OfficerLeadership
Don Scheck
Director Field Clinical EngineersLeadership
Libet Garber, Ph.D.
Director of Regulatory AffairsLeadership
Jan Bregman
Director, Quality SystemsLeadership
Matthew Rollins
Vice President Of Product DevelopmentLeadership
Sarah Hase, BS, CCRA
Director, Clinical OperationsLeadership
Jeff Terrell
DirectorBoard & advisors
Darshana Zaveri
DirectorBoard & advisors
Maria Berkman
Chairperson Of The BoardBoard & advisors
Uri Yaron
DirectorBoard & advisors
Gary Gershony
Scientific AdvisorBoard & advisors
Vivek Reddy
Scientific AdvisorBoard & advisors
Reinoud Knops
Scientific AdvisorBoard & advisors
Steven Girouard
DirectorBoard & advisors
TJ Ho
Quality EngineerTeam
Sterling Erickson
Principal Research And Development EngineerTeam
Rahul Veetekat
Principal R&d EngineerTeam

2 more people are available in the full profile.

Premium access

Complete people profiles for AtaCor Medical

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

Timeline of AtaCor Medical

3 dated milestones of AtaCor Medical across 11 years, from founding to its latest funding, stage changes and deals.

  1. Founded AtaCor Medical is founded.
  2. Funding First funding round of $8.8M.
  3. Funding Latest funding round, Series D, of $75.0M.

Competitors of AtaCor Medical

AtaCor Medical has 3 listed competitors in our database, 2 of them funded. They include AtriCure, CardioFocus and Kestra Medical Technologies.

Company NameDomainFoundedHQ LocationTotal fundingEmployeesDescription
atricure.com2000Mason, United States1,874
Cardiac ablation and occlusion devices for atrial fibrillation are provided.
cardiofocus.com1990Marlborough, United States$260.86M105
Endoscopic catheter for atrial fibrillation ablation is developed.
kestramedical.com2014Kirkland, United States$196M118
Medical devices are developed to support cardiovascular patients at risk.
Premium access

Detailed competitors of AtaCor Medical

The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.

  • Full competitor set
  • Operating metrics
  • Benchmarks
  • Competitive positioning

Verified entity values are shown only after access is granted.

Top companies in Cardiac and Vascular Disorders

3 companies that operate in the same segment as AtaCor Medical (Cardiac and Vascular Disorders) in United States, ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
Gene-editing therapies for coronary artery disease are developed.
2018Cambridge, Massachusetts, United StatesUSD 215.5 M255
Cardiac monitoring devices and applications are provided for heart health.
2010Mountain View, California, United StatesUSD 114.38 MUSD 6.18 M67
Therapies for lowering low-density lipoprotein cholesterol levels are developed.
1998Ann Arbor, Michigan, United StatesUSD 129.7 MUSD 332.31 M304
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Related news about Atacor Medical

Premium access

Complete news archive for AtaCor Medical

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about AtaCor Medical

AtaCor Medical was founded in 2014 and raised its 1st funding round 4 years after it was founded.

AtaCor Medical is headquartered in San Clemente, United States. It is registered at San Clemente, California, United States.

Rick Sanghera is the CEO of AtaCor Medical, as recorded in our data. They have also founded this company.

AtaCor Medical is a funded company, having raised a total of $136.8M across 4 funding rounds to date. The company's 1st funding round was a Series A of $8.8M, raised on Sep 2018.

AtaCor Medical has 15 employees.

Founded in 2014 and based in San Clemente, United States, AtaCor Medical operates in the medical device sector. An implantable pacemaker system is being developed, with the lead positioned in tissue above the heart to deliver pacing therapy. No leads or hardware are required inside or on the heart. Ventricular pacing or AV synchronous nodal therapy is enabled through this approach.

AtaCor Medical's top competitors include AtriCure, CardioFocus and Kestra Medical Technologies.

AtaCor Medical offers EV Temporary Pacing Lead System and EV-ICD Lead System.

AtaCor Medical has 7 investors. Key investors include Longview Partners, Broadview Ventures, aMoon, Hatteras Venture Partners, and CHV.

AtaCor Medical operates through Atacor Medical, Inc..

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available